Omeros Corp - Company Profile
Powered by 
All the sales intelligence you need on Omeros Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Omeros Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Omeros Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Omeros Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Omeros Corp's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Gregory A. Demopulos, M.D.
President; Chairman; Chief Executive Officer Executive BoardDr. Gregory A. Demopulos has been the Chairman, Chief Executive Officer and President of the company since 1994. Prior to this, he served as the Chief Financial Officer and Treasurer from January 2009 to October 2013 in an interim capacity. Dr. Demopulos also served as the Chief Medical Officer of the company from June 1994 to March 2010. Previously, he served on the Board of Smead Funds Trust.
David J. Borges
Chief Accounting Officer; Vice President - Finance; Treasurer Senior ManagementMr David J. Borges has been the Vice President, Finance, Chief Accounting Officer, and Treasurer of the company since 2024. Prior to this, he served as the vice president of finance and administration at Bulletproof 360, Inc. Previously, he served as the chief financial officer and vice president at Advanced Refreshment LLC from May 2009 to June 2014. He also served as the finance and business integration director at Merck & Co., Inc from July 2001 to May 2009. He served as the director of finance & administration/controller at Rosetta Inpharmatics in 1998.
Andreas Grauer, M.D.
Chief Medical Officer; Vice President Senior ManagementDr. Andreas Grauer has been the Chief Medical Officer and Vice President of the company since 2023. Prior to this, he served as the Chief Medical Officer at Federation Bio. Previously, he served as the chief medical officer at Corcept Therapeutics, Inc. He served as the vice president of global development, therapeutic area head, and co-chair of the franchise steering committee for bone, nephrology and inflammation at Amgen from December 2007 to December 2018.
George A. Gaitanaris, M.D., Ph.D.
Chief Scientific Officer; Vice President - Science Senior ManagementDr George A. Gaitanaris has been the Chief Scientific Officer since 2012 and Vice President of Science since 2006 for the company. Prior to this, he served as the Chief Scientific Officer at Nura Inc. Previously, he served as the President and Chief Scientific Officer at Primal Inc. He served as the Staff Scientist at the National Cancer Institute.
David W. Ghesquiere
Chief Business Development Officer; Vice President Senior ManagementMr David W. Ghesquiere has been the Chief Business Development Officer and Vice President of the company since 2024. Prior to this, he served as the Managing Director at Adrenaline Venture & Advisory LLC. Previously, he served as the senior vice president, corporate & business development at NanoString Technologies from November 2013 to December 2023. He served as the senior vice president, corporate & business development at Dendreon Corporation from 2011 to 2012. He also served in business development and alliance management roles at Aventis Pharmaceuticals.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer